INSIGHTS ON DRUG DEVELOPMENT
-
From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined
Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.
-
How Recent Trends Impact Bringing Your Molecule To Market
With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.
-
Innovative Strategies For Residual DNA And Viral Titre Quantitation
Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.
-
Navigating The Regulatory Space To Biosimilar Approval
The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.
-
An Unparalleled Window Into IBD Immune Response8/7/2024
Discover how Organ-Chips provide an unparalleled view into the human immune response to IBD and allow researchers to accurately model the intricacies of immune cell recruitment.
-
Enabling Quality By Design9/8/2025
Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.
-
R&D Excellence at Asymchem's UK Facility3/12/2026
Dave Henderson outlines R&D excellence at a UK facility, highlighting integrated labs, advanced experimentation, expert teams, and seamless progression from discovery through scale-up and manufacturing.
-
Screening For Amorphous Drug Substance5/6/2026
Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.
-
Transforming A Liquid Protein Solution Into A Solid Oral Dosage Form3/4/2025
Unlocking the potential of oral protein therapeutics requires innovative formulation and manufacturing strategies to overcome stability, absorption, and bioavailability challenges.
DRUG DEVELOPMENT SOLUTIONS
-
Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.
-
THUNDER Imager EM Cryo CLEM
In-depth understanding of cellular structural biology
The THUNDER Imager EM Cryo CLEM is a cryo light microscope featuring opto-digital THUNDER technology. It provides the imaging data and secure cryo conditions you need for successful experimental investigations concerning structural biology. Precisely identify cellular structures of interest thanks to high resolution, haze-free imaging with THUNDER technology, then transfer the specimen seamlessly to your EM.
-
The SpectraMax® Mini Multi-Mode Microplate Reader
Perform your favorite applications including ELISA, DNA and protein quantitation, cell viability, gene expression with a user-friendly reader.
-
As a dedicated center of excellence in this product family, we offer a high degree of versatility and tailored solutions to meet the specific needs of each client.
-
Applied Biosystems genetic analyzer, model 3500, integrated autosampler, 120 volts, serial# 24158-161.